BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23121359)

  • 1. Smokeless tobacco cessation in South Asian communities: a multi-centre prospective cohort study.
    Croucher R; Shanbhag S; Dahiya M; Kassim S; Csikar J; Ross L
    Addiction; 2012 Dec; 107 Suppl 2():45-52. PubMed ID: 23121359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smokeless tobacco cessation guidelines for health professionals in England.
    West R; McNeill A; Raw M;
    Br Dent J; 2004 May; 196(10):611-8. PubMed ID: 15153967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of successful short-term tobacco cessation in UK resident female Bangladeshi tobacco chewers.
    Croucher R; Shanbhag S; Dahiya M; Kassim S; McNeill A
    Addiction; 2012 Jul; 107(7):1354-8. PubMed ID: 22260392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial.
    Fagerström K; Gilljam H; Metcalfe M; Tonstad S; Messig M
    BMJ; 2010 Dec; 341():c6549. PubMed ID: 21134997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral tobacco cessation with UK resident Bangladeshi women: a community pilot investigation.
    Croucher R; Islam S; Jarvis MJ; Garrett M; Rahman R; Shajahan S; Howells G
    Health Educ Res; 2003 Apr; 18(2):216-23. PubMed ID: 12729180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smokeless tobacco cessation interventions: A systematic review.
    Nethan ST; Sinha DN; Chandan K; Mehrotra R
    Indian J Med Res; 2018 Oct; 148(4):396-410. PubMed ID: 30666002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural support and nicotine replacement therapy for smokeless tobacco cessation in Bangladesh, India and Pakistan: A pilot randomized controlled trial.
    Siddiqui F; Kanaan M; Croucher R; Bauld L; Fieroze F; Kumar P; Mazhar L; Pandey V; Jackson C; Huque R; Iqbal R; Siddiqi K;
    Addiction; 2024 May; ():. PubMed ID: 38769627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking cessation with smokeless tobacco and group therapy: an open, randomized, controlled trial.
    Tønnesen P; Mikkelsen K; Bremann L
    Nicotine Tob Res; 2008 Aug; 10(8):1365-72. PubMed ID: 18686184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cessation program for snuff-dippers with long-term, extensive exposure to Swedish moist snuff: A 1-year follow-up study.
    Wallström M; Bolinder G; Hassèus B; Hirsch JM
    Acta Odontol Scand; 2010 Nov; 68(6):377-84. PubMed ID: 20831357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of the nicotine lozenge and tobacco-free snuff for smokeless tobacco reduction.
    Ebbert JO; Severson HH; Croghan IT; Danaher BG; Schroeder DR
    Addict Behav; 2013 May; 38(5):2140-5. PubMed ID: 23454876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-Term Smoking Cessation in English Resident Adults of Bangladeshi Origin: A Service Review.
    Kassim S; Al-Haboubi M; Croucher R
    Nicotine Tob Res; 2016 Apr; 18(4):410-5. PubMed ID: 25957437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing an immediate cessation versus reduction approach to smokeless tobacco cessation.
    Schiller KR; Luo X; Anderson AJ; Jensen JA; Allen SS; Hatsukami DK
    Nicotine Tob Res; 2012 Aug; 14(8):902-9. PubMed ID: 22218402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interventions for the treatment of smokeless tobacco use.
    Ebbert JO; Fagerstrom K
    CNS Drugs; 2012 Jan; 26(1):1-10. PubMed ID: 22136150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting smoking cessation in Pakistani and Bangladeshi men in the UK: pilot cluster randomised controlled trial of trained community outreach workers.
    Begh RA; Aveyard P; Upton P; Bhopal RS; White M; Amos A; Prescott RJ; Bedi R; Barton P; Fletcher M; Gill P; Zaidi Q; Sheikh A
    Trials; 2011 Aug; 12():197. PubMed ID: 21854596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical Validation of Self-Reported Smokeless Tobacco Abstinence among Smokeless Tobacco Users: Results from a Clinical Trial of Varenicline in India.
    Jain R; Jhanjee S; Jain V; Gupta T; Mittal S; Chauhan P; Raghav R; Goelz P; Schnoll RA
    J Psychoactive Drugs; 2015; 47(4):331-5. PubMed ID: 26317285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine Metabolite Ratio Is Associated With Lozenge Use But Not Quitting in Smokeless Tobacco Users.
    Ebbert JO; Severson HH; Danaher BG; Benowitz NL; Schroeder DR
    Nicotine Tob Res; 2016 Mar; 18(3):366-70. PubMed ID: 25977408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking and smokeless tobacco use among male south Asian migrants in the United Arab Emirates: a cross-sectional study.
    Ali R; Loney T; Al-Houqani M; Blair I; Aziz F; Al Dhaheri S; El Barazi I; Soteriades ES; Shah SM
    BMC Public Health; 2020 May; 20(1):815. PubMed ID: 32473627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.
    Tulloch HE; Pipe AL; Els C; Clyde MJ; Reid RD
    BMC Med; 2016 Jun; 14():80. PubMed ID: 27233840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized phase II clinical trial of high-dose nicotine patch therapy for smokeless tobacco users.
    Ebbert JO; Croghan IT; Schroeder DR; Hurt RD
    Nicotine Tob Res; 2013 Dec; 15(12):2037-44. PubMed ID: 23873976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users.
    Ebbert JO; Dale LC; Patten CA; Croghan IT; Schroeder DR; Moyer TP; Hurt RD
    Nicotine Tob Res; 2007 Jan; 9(1):43-52. PubMed ID: 17365735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.